<VariationArchive RecordType="classified" VariationID="5518" VariationName="NM_014363.6(SACS):c.4033dup (p.Gln1345fs)" VariationType="Duplication" Accession="VCV000005518" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2015-08-20" MostRecentSubmission="2015-08-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20557" VariationID="5518">
      <GeneList>
        <Gene Symbol="SACS" FullName="sacsin molecular chaperone" GeneID="26278" HGNC_ID="HGNC:10519" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23328830" stop="23433702" display_start="23328830" display_stop="23433702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23902964" stop="24007840" display_start="23902964" display_stop="24007840" Strand="-" />
          </Location>
          <OMIM>604490</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014363.6(SACS):c.4033dup (p.Gln1345fs)</Name>
      <CanonicalSPDI>NC_000013.11:23339842:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>13q12.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="23339842" stop="23339843" display_start="23339842" display_stop="23339843" variantLength="1" positionVCF="23339842" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="23913981" stop="23913982" display_start="23913981" display_stop="23913982" variantLength="1" positionVCF="23913981" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>Q1345fs</ProteinChange>
      <ProteinChange>Q1198fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.23913983dup" Assembly="GRCh37">
            <Expression>NC_000013.10:g.23913983dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.23339844dup" Assembly="GRCh38">
            <Expression>NC_000013.11:g.23339844dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012342.1" sequenceAccession="NG_012342" sequenceVersion="1" change="g.98860dup">
            <Expression>NG_012342.1:g.98860dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278055.2" sequenceAccession="NM_001278055" sequenceVersion="2" change="c.3592dup">
            <Expression>NM_001278055.2:c.3592dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001264984.1" sequenceAccession="NP_001264984" sequenceVersion="1" change="p.Gln1198fs">
            <Expression>NP_001264984.1:p.Gln1198fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014363.6" sequenceAccession="NM_014363" sequenceVersion="6" change="c.4033dup" MANESelect="true">
            <Expression>NM_014363.6:c.4033dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055178.3" sequenceAccession="NP_055178" sequenceVersion="3" change="p.Gln1345fs">
            <Expression>NP_055178.3:p.Gln1345fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="604490.0007" DB="OMIM" />
        <XRef Type="rs" ID="606231163" DB="dbSNP" />
        <XRef ID="CA253515" DB="ClinGen" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 14718706 Fig. 2 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014363.6(SACS):c.4033dup (p.Gln1345fs) AND Charlevoix-Saguenay spastic ataxia" Accession="RCV000005853" Version="5">
        <ClassifiedConditionList TraitSetID="1544">
          <ClassifiedCondition DB="MedGen" ID="C1849140">Charlevoix-Saguenay spastic ataxia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-01-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2004-01-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-08-20" MostRecentSubmission="2015-08-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14718706</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1544" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5931" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPASTIC ATAXIA 6, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charlevoix-Saguenay spastic ataxia</ElementValue>
                <XRef ID="MONDO:0010041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic ataxia of Charlevoix-Saguenay</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPAX6</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARSACS</ElementValue>
                <XRef ID="NBK1255" DB="GeneReviews" />
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SACS</ElementValue>
                <XRef Type="MIM" ID="270550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is clinically characterized by a progressive cerebellar ataxia, peripheral neuropathy, and spasticity. Disease onset of classic ARSACS is often in early childhood, leading to delayed walking because of gait unsteadiness in very young toddlers, while an increasing number of individuals with disease onset in teenage or early-adult years are now being described. Typically the ataxia is followed by lower-limb spasticity and later by peripheral neuropathy â€“ although pronounced peripheral neuropathy has been observed as a first sign of ARSACS. Oculomotor disturbances, dysarthria, and upper-limb ataxia develop with slower progression than the other findings. Brain imaging demonstrates atrophy of the superior vermis and the cerebellar hemisphere with additional findings on MRI, such as linear hypointensities in the pons and hyperintense rims around the thalami. Many affected individuals (though not all) have yellow streaks of hypermyelinated fibers radiating from the edges of the optic disc noted on ophthalmologic exam, and thickened retinal fibers can be demonstrated by optical coherence tomography. Mild intellectual disability, hearing loss, and urinary urgency and incontinence have been reported in some individuals.</Attribute>
                <XRef ID="NBK1255" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4910" />
                <XRef ID="4910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301432</ID>
                <ID Source="BookShelf">NBK1255</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="98" DB="Orphanet" />
              <XRef ID="C1849140" DB="MedGen" />
              <XRef ID="MONDO:0010041" DB="MONDO" />
              <XRef Type="MIM" ID="270550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26035" SubmissionDate="2015-08-18" DateLastUpdated="2015-08-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604490.0007_SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE" title="SACS, 1-BP INS, 1859C_SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE" />
        <ClinVarAccession Accession="SCV000026035" DateUpdated="2015-08-20" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-01-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sisters with spastic ataxia of the Charlevoix-Saguenay type (ARSACS; 270550), born of consanguineous parents in southern Italy, Criscuolo et al. (2004) identified homozygosity for a 1-bp insertion, 1859insC, in the SACS gene, resulting in a frameshift and a premature stop codon at position 599. The resulting protein lacked 3,230 amino acids. Both sisters showed a clinical phenotype similar to other reported patients with ARSACS; one of the sisters also had mental retardation and hypoacusis.</Attribute>
              <Citation>
                <ID Source="PubMed">14718706</ID>
              </Citation>
              <XRef DB="OMIM" ID="270550" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SACS" />
          </GeneList>
          <Name>SACS, 1-BP INS, 1859C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1859C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604490.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26035" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE" MappingRef="Preferred">
        <MedGen CUI="C1849140" Name="Charlevoix-Saguenay spastic ataxia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

